Amylyx Pharmaceuticals Stock Forecast

Buy candidate since Jun 12, 2026 Gain 21.93%

The Amylyx Pharmaceuticals, Inc. stock price gained 2.01% on the last trading day (Friday, 26th Jun 2026), rising from $17.44 to $17.79. It has now gained 7 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 5.13% from a day low at $17.15 to a day high of $18.03. The price has risen in 9 of the last 10 days and is up by 27.89% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 58 thousand more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $63.37 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $17.25, a level that may pose a second chance to hit a runner. According to fan-theory $22.37 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

AMLX Signals & Forecast

Mostly positive signals in the chart today. The Amylyx Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $16.54 and $14.48. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 39.64%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Amylyx Pharmaceuticals, Inc. stock

Amylyx Pharmaceuticals, Inc. finds support from accumulated volume at $17.44 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.88 between high and low, or 5.13%. For the last week, the stock has had daily average volatility of 6.68%.

The Amylyx Pharmaceuticals, Inc. stock is extremely overbought on RSI14 (90). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken. Since the Amylyx Pharmaceuticals, Inc. has been rising for 7 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $17.22 (-3.20%) (This stock has high daily movements and this gives high risk. The RSI14 is 90 and this increases the risk substantially. There is a buy signal from a pivot bottom found 26 days ago.)

Trading Expectations (AMLX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Amylyx Pharmaceuticals, Inc. to open at $17.66, and during the day (based on 14 day Average True Range), to move between $17.31 and $18.27, which gives a possible trading interval of +/-$0.96 (+/-5.53%) up or down from last closing price. If Amylyx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 5.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $17.44 (1.97%) than the resistance at $18.36 (3.20%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Amylyx Pharmaceuticals, Inc. stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 4.892 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $17.66 ( 0.749%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk